The authors stated that the risk of receiving a diagnosis of PCa increased when PSA levels exceeded the median PSA levels for the general population, both for 40–49 year-old individuals (with a 14.6-fold increased risk) and for 50–59 year-old men (with a 7.6-fold increased risk). The gene discussed is KLK3; the disease is posterior cortical atrophy.